23.11.2014 Views

20 CHAPTER 3 REVIEW OF CONJOINT ANALYSIS THEORY ...

20 CHAPTER 3 REVIEW OF CONJOINT ANALYSIS THEORY ...

20 CHAPTER 3 REVIEW OF CONJOINT ANALYSIS THEORY ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

contain any trace of genetically modified ingredients. One participant believed that food<br />

products should be labeled GMO only if contents contain more than 50% of genetically<br />

modified ingredients. Another believed that labeling should not be required regardless of<br />

the amount of genetically modified ingredients. When asked specifically if they would<br />

buy products with a GMO label, most participants said yes. Most participants said, that as<br />

consumers they have the right to know about the production process of the food they eat,<br />

and as a result, products produced by biotechnology should be labeled as such. In<br />

addition, participants believed that biotechnology is beneficial, and is a process, that once<br />

they have more information about, would more readily embrace. The focus group<br />

discussion indicated that both logo and text disclosure were important attributes. Location<br />

of the disclosure was also important, and the respondents thought that any easily<br />

identifiable logo would aid their shopping and purchase decisions. Based on these results,<br />

the attributes selected for the mail survey are presented in table 3.1.<br />

Table 3.1 Attributes and Their Levels Used in Survey<br />

Attribute<br />

Levels<br />

Text disclosure of biotech<br />

Ingredients<br />

Biotech logo<br />

Location of a Biotech logo<br />

Simple text disclosure<br />

Text disclosure with benefits of the technology<br />

No text<br />

Present<br />

Absent<br />

Principal Display Panel<br />

Informational Panel<br />

The Experimental Design<br />

The focus-group discussion identified three important attributes and levels, which<br />

were combined to form hypothetical biotech labels. Levels were based on results from the<br />

focus group discussion, and FDA’s labeling requirement guidelines were used to ensure<br />

that realistic scenarios were presented.<br />

Respondents’ evaluation and measurement of<br />

31

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!